NEW YORK & LONDON & HONG KONG–(BUSINESS WIRE)–Enfusion, Inc. (NYSE: ENFN), a leading provider of cloud-native investment management software and services, today announced that it will report its fourth quarter fiscal year 2021 financial results after the U.S. financial markets close on Thursday, March 24, 2022.
Webcast and Conference Call Details
In conjunction with this announcement, Enfusion will host a conference call at 2:00 PM (PT) / 5:00 PM (ET) on Thursday, March 24, 2022 during which management will discuss fourth quarter results and provide commentary on business performance and financial guidance. A question-and-answer session will follow the prepared remarks. To access this call, dial (844) 200-6205 (domestic) or (929) 526-1599 (international). The conference ID number is 738165. A live webcast of this conference call will be available on the Investor Relations page of Enfusion�s website, http://ir.enfusion.com, and a replay will be archived on the website as well.
About Enfusion
Enfusion’s investment management software-as-a-service platform removes traditional information boundaries, uniting front-, middle- and back-office teams on one cloud-native system. Through its software, analytics, and middle/back-office managed services, Enfusion creates enterprise-wide cultures of real-time, data-driven intelligence, boosting agility, and powering growth. Enfusion partners with 650+ investment managers from ten global offices spanning five continents.
Source: Enfusion, Inc.
Source Code: ENFN-IR
ENFN-CORP
Contacts
Investors
Ignatius Njoku
Ignatius.njoku@enfusion.com
Press
Prosek Partners
pro-enfusion@prosek.com
New slot tournament, Blackjack Quest and poker event here this month SYDNEY--(BUSINESS WIRE)--A new month…
AUBURN HILLS, Mich.--(BUSINESS WIRE)--#safety--Teijin Automotive Technologies held a ribbon cutting today to celebrate the opening…
VANCOUVER--(BUSINESS WIRE)--Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) (ASX:CSC) announced the voting results from…
DUBLIN--(BUSINESS WIRE)--The "Indonesia International Remittance Market Business and Investment Opportunities - Analysis by Transaction Value…
KCAS Bio continues to expand its global reach and has selected Crux Biolabs (Melbourne, Australia)…
Strengthens end-to-end RCM offering to healthcare providers Expands service capabilities to US physicians’ practices, and…